Cui Xuelian

Jan 9, 2025 | pubs.acs.org | Eunsol Jeon |Min Kim |Min Lee |Cui Xuelian

IntroductionClick to copy section linkSection link copied!Cancer, a major life-threatening disease, underscores the need for accurate diagnosis and treatment. (1) Research on real-time cancer biomarkers analysis is imperative for early detection, personalized therapy, and prognostic prediction. During cancer progression, various cancer biomarkers, NADH-dependent reductases, particularly human NAD(P)H:quinone oxidoreductase 1 (hNQO1) and nitroreductases (NTRs), are often overexpressed.